Correction: Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma

Goldberg JL, Navid F, Hank JA, et al. Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma. J ImmunoTherapy Cancer 2020;8:e000590. doi: 10.1136/jitc-2020-000590

Since the online publication of this article, the author names ‘Jacquelyn A Hank’ and ‘Stephen D Gillies’ were spelt incorrectly as ‘Jacqueline A Hank’ and ‘Steven D Gillies’. This has now been corrected.